Literature DB >> 27960158

Risk Factors.

T Uehara, O Y Bang, J S Kim, K Minematsu, R Sacco.   

Abstract

Studies investigating risk factors for intracranial atherosclerosis (ICAS) have been infrequent. However, due to recent availability of non-invasive vascular imaging techniques that can assess intracranial cerebral arteries, there are a growing number of studies on risk factors for ICAS. Conventional vascular risk factors such as hypertension, diabetes, hypercholesterolemia and cigarette smoking are risk factors for ICAS. However, it remains uncertain whether there is a difference in risk factors between ICAS and extracranial atherosclerosis (ECAS). It also remains unclear why ICAS is more common in Asians and Blacks than in Caucasians. Although we reviewed available evidences on these differences, the review was limited because studies were heterogeneous in the definition of risk factors, diagnostic method, and characteristics of study subjects (hospitalized vs. community) or cerebral vessels (symptomatic vs. asymptomatic). Nevertheless, it seems that hypercholesterolemia is more closely associated with ECAS than ICAS. The difference in hypercholesterolemia prevalence is one of the main reasons for racial differences in the location of cerebral atherosclerosis. Intracranial arteries contain higher antioxidant level than extracranial arteries and may be more vulnerable to risk factors that deplete antioxidants (e.g., metabolic syndrome and diabetes mellitus). Intracranial arteries may be more vulnerable to factors associated with hemodynamic stress (e.g., advanced, salt-retaining hypertension and arterial tortuosity) because of a smaller diameter, thinner media and adventitia, and fewer elastic medial fibers than extracranial arteries. Additionally, non-atherosclerotic arterial diseases (e.g., moyamoya disease) that commonly occur in the intracranial arteries of East Asians may contaminate the reports of ICAS cases. Various genes, including RNF 213, might also explain racial differences in atherosclerotic location. Prospective, well-designed risk factor and genetic studies should be performed in a homogeneous group of patients with diverse ethnicities. These efforts are essential in the prevention of atherosclerotic diseases based on adequate knowledge of the risk factors and pathogenesis.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27960158     DOI: 10.1159/000448301

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN: 0300-5186


  5 in total

1.  Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?

Authors:  James A Reiffel
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

2.  Association of Newly Found Asymptomatic Intracranial Artery Stenosis and Ideal Cardiovascular Health Metrics in Chinese Community Population.

Authors:  Changfeng Fan; Qian Zhang; Shufeng Zhang; Anxin Wang; Xinwei Bi; Shengyun Chen; Zhaoxia Li; Shouling Wu; Xingquan Zhao
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

3.  Diagnostic Significance of Plasma Levels of Novel Adipokines in Patients With Symptomatic Intra- and Extracranial Atherosclerotic Stenosis.

Authors:  Fang Yu; Xiaoqing Zhou; Zhibin Li; Xianjing Feng; Di Liao; Zeyu Liu; Qin Huang; Xi Li; Qidong Yang; Bo Xiao; Jian Xia
Journal:  Front Neurol       Date:  2019-11-19       Impact factor: 4.003

4.  Association of antinuclear antibodies with the risk of intracranial arterial stenosis.

Authors:  Yong-An Sun; Qiu Han; Xiao-He Hou; Xian-Zhen Peng; Lin Tong; Xu Zheng; Jin-Tai Yu; Lan Tan
Journal:  Aging (Albany NY)       Date:  2020-01-21       Impact factor: 5.682

5.  Different risk factors in identical features of intracranial atherosclerosis plaques in the posterior and anterior circulation in high-resolution MRI.

Authors:  Ziqi Xu; Mingyao Li; Jinhao Lyu; Zhikai Hou; Jianfeng He; Dapeng Mo; Feng Gao; Xin Liu; Binbin Sui; Mi Shen; Yuesong Pan; Yongjun Wang; Xin Lou; Zhongrong Miao; Benyan Luo; Ning Ma
Journal:  Ther Adv Neurol Disord       Date:  2020-03-13       Impact factor: 6.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.